| Term 
 | Definition 
 
        | improved mood, modulation of anxiety, sleep regulation, appetite regulation, and regular body temp |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | improved mood, fight or flight, mental organization, rewards, cardiovascular |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | improved mood, psychosis, attention/cognition, reward/reinforcement of pleasure activities, motor function |  | 
        |  | 
        
        | Term 
 
        | acetylcholine (ACH)-antagonism |  | Definition 
 
        | urinary retention, dry mouth, constipation, tachycardia, learning, muscle action |  | 
        |  | 
        
        | Term 
 
        | Histamine (H1)-antagonism |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | treat BOTH depression and anxiety |  | Definition 
 
        | SSRIs, SNRIs, MAOIs and atypical antidepressants |  | 
        |  | 
        
        | Term 
 
        | SSRIs (selective serotonin reuptake inhibitors) |  | Definition 
 
        | fluoxetine, sertraline, fluvoxamine, citalopram, escitalopram, paroxetine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | anxiety, agitation, akathiesia, panic, insomnia, sexual dysfunction, hyponatremia, decreased in platelet aggregation; bleeding risk |  | 
        |  | 
        
        | Term 
 
        | SNRI (selective norepinephrine reuptake inhibitors) |  | Definition 
 
        | Amitriptyline, clomipramine, desimipramine, doxepin, duloxetine, imipramine, nortriptyline, venlafaxine/desvenlafacine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | severe sedation, constipation, weight gain, cardiovascular, orthostatic hypotension, sexual dysfunction, insomnia, sweating and tremors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | phenelzine, tranylcyromine and selegiline |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | orthostatic hypertension, drowsiness, constipation, tremors, hypertensive crisis, anxiety |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | nefazodone, trazodone, buproprion, mirtazapine, and vilazodone |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits reuptake of serotonin and NE; 5-HT2 and alpha 1 receptor antagonist |  | 
        |  | 
        
        | Term 
 
        | adverse effects of nefazodone |  | Definition 
 
        | somnolence, dizziness, constipation, orthostatic hypoTN and liver failure (RARE) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits reuptake of serotonin, histamine, alpha 1 adrenergic receptor antagonist |  | 
        |  | 
        
        | Term 
 
        | adverse effects of trazodone |  | Definition 
 
        | blurred vision, dizziness, dry mouth, nasal congestion and priapism--used mainly for SE (drowsiness) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | blocks reuptake of NE and DO--uses include depression, smoking cessation and ADHD |  | 
        |  | 
        
        | Term 
 
        | adverse effects of bupropion |  | Definition 
 
        | HA, dry mouth, weight loss, insomnia and agitation/ anxiety |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | presynaptic alpha 2 antag that effects stimulates NE and serotonin release; potent antag of 5-HT2, 5-HT3 and histamine receptors |  | 
        |  | 
        
        | Term 
 
        | adverse effects of mirtazapine |  | Definition 
 
        | somnolence, weight gain, increased appetite, constipation, xerostomia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | selective serotonin reuptake inhibitor and partial agonist 5-HT1A receptors (exact MOA is not entirely known) |  | 
        |  | 
        
        | Term 
 
        | adverse effects of vilazodone |  | Definition 
 
        | GI-diarrhea, nausea, neurological (dizziness and insomnia), cardiovascular (palpitations, ventricular premature beats) |  | 
        |  |